Home › GSK to buy HIV drugs from Bristol-Myers Squibb for initial $350 million
 

Keywords :   


GSK to buy HIV drugs from Bristol-Myers Squibb for initial $350 million

2015-12-18 11:02:16| Biotech - Topix.net

It used to dominate the market but ViiV's 2014 sales of 1.5 billion pounds were less than a quarter of the HIV revenue generated by market leader Gilead Sciences ViiV will pay an initial $317 million to buy late-stage HIV drug candidates from Bristol-Myers, including a phase III development treatment fostemsavir, plus $33 million for its preclinical assets. HIV is often treated by mixing at least three medicines together because of the ability of the virus that causes AIDS to mutate and become drug-resistant.

Tags: buy million initial drugs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Subtropical Storm Patty Graphics
02.11Atlantic Tropical Weather Outlook
02.11Eastern North Pacific Tropical Weather Outlook
02.11Tropical Storm Lane Graphics
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Forecast Discussion Number 4
02.11Subtropical Storm Patty Wind Speed Probabilities Number 2
02.11Summary for Tropical Storm Lane (EP3/EP132024)
More »